News & Insights

April 9, 2025 Over-the-counter (OTC) drugs play a vital role in public health by providing consumers with access to safe and effective treatments [...]

With a new administration comes a fresh wave of changes at the FDA, bringing shifts in leadership, policy priorities, and regulatory approaches. These adjustments will impact a [...]

April 1, 2025 On Monday, a federal judge in Texas ruled that the FDA overstepped its authority when it issued its Final Rule: [...]

March 21, 2025 | Expert Insights The recent approval of ZYN nicotine pouches by the U.S. Food and Drug Administration (FDA) on January [...]

March 4, 2025 | Expert Insights | Authored by Accorto Regulatory Solutions & Ward Law Office Inventors of new medical technologies often face [...]

November 15, 2024 | Regulatory Insights | Author: Neel Parmar For a successful FDA submission in the US medical device industry, demonstrating the [...]

FDA Granted Regulation of Synthetic Nicotine: What You Need to Know US Government is Redefining "Tobacco Products" On March 15th, 2022 [...]

Don't Just Win a PMTA Battle, Win the PMTA War At Accorto Regulatory Solutions, we work with companies who are pushing back on the FDA’s [...]

New Bill Aims to Regulate Synthetic Nicotine in 2022 On December 15, 2021, Congresswoman Mikie Sherrill from New Jersey announced the introduction of the [...]